3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
123
Recurrence
12
Neoplasms
8
Immunoglobulin Light-chain Amyloidosis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms, Plasma Cell
5
Smoldering Multiple Myeloma
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Plasmacytoma
2
Plasmablastic Lymphoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Amyloidosis
2
Acute Kidney Injury
2
Triple Negative Breast Neoplasms
1
Proteostasis Deficiencies
1
Primary Myelofibrosis
1
Paraproteinemias
1
Non-small Cell Lung Cancer With STK11/LKB1 Mutation
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Plasma Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cyclophosphamide
9
mogamulizumab
6
Biopsy
6
fludarabine
5
fludarabine phosphate
4
Specimen Handling
4
Immunoglobulin G
4
Disulfides
4
Brentuximab Vedotin
4
ruxolitinib
3
romidepsin
3
pembrolizumab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Etoposide
3
Busulfan
3
hypericin
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Melphalan
2
Depsipeptides
2
tofacitinib
1
thymoglobulin
1
tazemetostat
1
talimogene laherparepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
daratumumab
×
1 year
×
Clear all
No trials found.